Andrew Lonsdale

Andrew Lonsdale

Auto-generated profile, based on publicly available information

Andrew Lonsdale

Peter MacCallum Cancer Centre

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2017 in Plant Physiology
Verified
Journal Article
Open access
PDF file
Kim JohnsonKim Johnson
Kim Johnson
ACAndrew M. Cassin
Andrew M. Cassin
ALAndrew Lonsdale
Andrew Lonsdale
GWGane Ka-Shu Wong
Gane Ka-Shu Wong
DSDouglas E. Soltis
Douglas E. Soltis
CSC. J. Schultz
C. J. Schultz
Evaluation of hydroxyproline-rich glycoproteins identified in 1KP transcriptomic data sets to gain insight into their evolutionary history from chlorophyte alga

26 April 2017 in Plant Physiology
Verified
Journal Article
Open access
PDF file
Kim JohnsonKim Johnson
Kim Johnson
ACAndrew M. Cassin
Andrew M. Cassin
ALAndrew Lonsdale
Andrew Lonsdale
ABAntony Bacic
Antony Bacic
Monika S. DoblinMonika S. Doblin
Monika S. Doblin
CSC. J. Schultz
C. J. Schultz
An innovative bioinformatics pipeline to identify and classify a plant-specific superfamily of cell wall hydroxyproline-rich glycoproteins provides evolutionary

15 July 2022 in Blood Advances
Verified
Journal Article
Open access
PDF file
BSBreon M Schmidt
Breon M Schmidt
LBLauren M. Brown
Lauren M. Brown
GRGeorgina Ryland
Georgina Ryland
ALAndrew Lonsdale
Andrew Lonsdale
HKHansen J. Kosasih
Hansen J. Kosasih
AOAlicia Oshlack
Alicia Oshlack
Key Points. ALLSorts is a gene expression classifier for B-cell acute lymphoblastic leukemia, which predicts 18 distinct genomic subtypes.Correctly identified s

1 September 2019 in GigaScience
Verified
Journal Article
Open access
PDF file
PGPeter Georgeson
Peter Georgeson
ASAnna Syme
Anna Syme
CSClare Sloggett
Clare Sloggett
JCJessica Chung
Jessica Chung
HDHarriet Dashnow
Harriet Dashnow
BPBernard Pope
Bernard Pope
Bioinformatics software tools are often created ad hoc, frequently by people without extensive training in software development. In particular, for beginners, the barrier to entry in bioinformatics software development is high, especially if they want to adopt good programming practices. Even experienced developers do not always follow best practices. This results in the proliferation of poorer-quality bioinformatics software, leading to limited scalability and inefficient use of resources; lack of reproducibility, usability, adaptability, and interoperability; and erroneous or inaccurate results. We have developed Bionitio, a tool that automates the process of starting new bioinformatics software projects following recommended best practices. With a single command, the user can create a new well-structured project in 1 of 12 programming languages. The resulting software is functional, carrying out a prototypical bioinformatics task, and thus serves as both a working example and a template for building new tools. Key features include command-line argument parsing, error handling, progress logging, defined exit status values, a test suite, a version number, standardized building and packaging, user documentation, code documentation, a standard open source software license, software revision control, and containerization. Bionitio serves as a learning aid for beginner-to-intermediate bioinformatics programmers and provides an excellent starting point for new projects. This helps developers adopt good programming practices from the beginning of a project and encourages high-quality tools to be developed more rapidly. This also benefits users because tools are more easily installed and consistent in their usage. Bionitio is released as open source software under the MIT License and is available at https://github.com/bionitio-team/bionitio.

13 December 2023 in Blood Advances
Verified
Journal Article
Open access
PDF file
AGAllen Gu
Allen Gu
BSBreon Schmidt
Breon Schmidt
ALAndrew Lonsdale
Andrew Lonsdale
RJRoshan Niloofa Niloofa Mohamed Jalaldeen
Roshan Niloofa Niloofa Mohamed Jalaldeen
HKHansen J. Kosasih
Hansen J. Kosasih
AOAlicia Oshlack
Alicia Oshlack

3 February 2023 in F1000Research
Verified
Journal Article
Open access
PDF file
ALAndrew Lonsdale
Andrew Lonsdale
AHAndreas Halman
Andreas Halman
LBLauren Brown
Lauren Brown
HKHansen Kosasih
Hansen Kosasih
PEPaul Ekert
Paul Ekert
AOAlicia Oshlack
Alicia Oshlack
Cancer is driven by mutations of the genome that can result in the activation of oncogenes or repression of tumour suppressor genes. In acute lymphoblastic leukemia (ALL) focal deletions in IKAROS family zinc finger 1 (IKZF1) result in the loss of zinc-finger DNA-binding domains and a dominant negative isoform that is associated with higher rates of relapse and poorer patient outcomes. Clinically, the presence of IKZF1 deletions informs prognosis and treatment options. In this work we developed a method for detecting exon deletions in genes using RNA-seq with application to IKZF1. We developed a pipeline that first uses a custom transcriptome reference consisting of transcripts with exon deletions. Next, RNA-seq reads are mapped using a pseudoalignment algorithm to identify reads that uniquely support deletions. These are then evaluated for evidence of the deletion with respect to gene expression and other samples. We applied the algorithm, named Toblerone, to a cohort of 99 B-ALL paediatric samples including validated IKZF1 deletions. Furthermore, we developed a graphical desktop app for non-bioinformatics users that can quickly and easily identify and report deletions in IKZF1 from RNA-seq data with informative graphical outputs.